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Purpose: To identify the genetic defect in an autosomal dominant isolated ectopia lentis (EL) family.
Methods: Detailed family history and clinical data were collected from the family including sixteen patients with isolated
EL. Blood samples of nine patients, one normal person and two unknown children’s were collected. Genomic DNA was
extracted from leukocytes of peripheral blood. Genotyping was performed by microsatellite markers and logarithm-of-
odds (LOD) scores were calculated using the LINKAGE Programs. Mutation screening in the candidate gene, fibrillin-1
(FBN1), was performed by direct sequencing.
Results: Linkage to the FBN1 locus is verified. Mutation screening in FBN1 identified a C>T transition at nucleotide
position c.2920. This nucleotide change results in the cysteine substitution for highly conserved arginine at codon 974
(p.R974C). This mutation is identified in all affected individuals but is not found in 50 control healthy people.
Conclusions: A novel mutation of FBN1 results in an arginine to cysteine residue (p.R974C) substitution, which is
responsible for the patients with isolated EL in this Chinese family.
Ectopia lentis (EL) is an inherited connective disorder
characterized  by  lens  dislocation.  Most  cases  of  EL  are
associated  with  Marfan  syndrome,  a  genetic  autosomal
dominant  disorder  that  is  characterized  by  manifestations
involving  the  cardiovascular,  skeletal,  and  ocular  systems
[1].
Mutations of the fibrillin-1 (FBN1) gene on chromosome
15q have been described in patients with classical Marfan
syndrome, neonatal MFS, aortic aneurysms, ectopia lentis,
Marfanoid  skeletal  features,  familial  arachnodactyly,
Shprintzen-Goldberg  syndrome,  Weill-Marchesani
syndrome, and severe progressive kyphoscoliosis [2-6].
An isolated EL pedigree has been reported several times
in different races [7-10]. This kind of phenotype may be an
independent subtype caused by specific FBN1 mutations and
other regulatory factors.
In this study, we recruited a Chinese family affected with
isolated EL. Linkage to the FBN1 locus is identified. Mutation
screening in FBN1 identified a C>T transition at nucleotide
position  c.2920.  This  nucleotide  change  results  in  the
substitution of highly conserved arginine by cysteine at codon
974 (p.R974C). The mutation is cosegregated in the patients
but not found in the 50 control subjects from the same ethnic
background.
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METHODS
Patients  and  clinical  data:  The  five-generation  family
enrolled in this study was found in a Northwestern province
of China. Clinical examination, peripheral blood collection,
and DNA extraction were performed in the Department of
Ophthalmology,  Peking  Union  Medical  College  Hospital,
Beijing,  China.  Informed  consent  in  accordance  with  the
Declaration of Helsinki and the Institutional Review Board
and Ethics Committee of Peking city was obtained from all
participants. The family includes sixteen confirmed patients
with isolated EL. Blood samples of nine patients, one normal
person, and two younger children (the symptom of ectopia
lentis occurs from 17 to 20 in this family) were collected
(Figure 1). Clinical data of these subjects was ascertained by
case records of surgeries and detailed ocular examinations.
Genotyping and linkage analysis: With fluorescently labeled
microsatellite markers (Sangon Biotech Co,. Ltd, Shanghai,
China), linkage analysis of candidate gene region at 15q was
done  on  the  DNA  samples  from  12  ophthalmologically
examined  individuals.  Two-point  linkage  analysis  was
performed by MLINK from LINKAGE Program Package.
Mutation analysis: All coding exons of FBN1 were amplified
by polymerase chain reaction (PCR) using a set of sixty-five
pairs of primers (Appendix 1) [11]. The standard PCR reaction
(50 μl) contained 80 ng of genomic DNA, 10 pM each primer,
25  μl  TaqMix  and  water.  The  thermal  profile  included
denaturation for 5 min, followed by 36 cycles of denaturation
(30 s at 95 °C), annealing (30 s at 54 °C-60 °C), and extension
(45 s at 72 °C), followed by a final step of extension (10 min
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945at 72 °C). The PCR products were sequenced on an ABI3730
Automated Sequencer (PE Biosystems, Foster City, CA).
RESULTS
Clinical findings: We identified a five-generation family with
sixteen  confirmed  individuals  affected  with  isolated  EL
(Figure 2). Eleven patients’ blood samples were collected. All
participated patients have received surgery. The onset age of
patients with EL was around 15 to 30 years. Patient II-1 was
a seventy-eight-year old woman who, except for the EL, had
no  other  Mafan-related  disorders.  The  stature  of  all  the
patients in this family was shorter than 1.70 m. We did not
find the cardiovascular system, the skeleton system, and other
Marfan-related syndromes in the collected ten patients.
Linkage  and  haplotype  analysis:  We  obtained  positive
logarithm-of-odds (LOD) scores with markers at 15q (Table
1). A maximum positive LOD score of 2.61 at θ=0.00 was
obtained by marker D15S126. The haplotype shows complete
cosegregation  in  all  the  9  affected  individuals  who  were
studied (Figure 1).
Figure 1. Pedigree and haplotype of the family. A five-generation pedigree with twelve available members is shown. Four markers adjacent
to FBN1 were selected. The disease haplotype (represented by the black bar) cosegregated in all affected members but was not shared by
unaffected ones.
Figure 2. Slit lamp photograph showing dislocation of the patient’s lens (III:14 in Figure 1). Arrows indicate the edge of the lens.
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946Mutation  analysis:  Sequencing  of  FBN1  shows  a
heterozygous  C>T  change  in  the  affected  individuals  at
nucleotide position c.2920 (Figure 3). This nucleotide change
results  in  a  cysteine  substitution  for  a  highly  conserved
arginine at codon 974 (p.R974C; Figure 4). All affected family
members  presented  this  nucleotide  change.  Haplotyping
shows individual IV-15 was affected, while individual V-1
was  unaffected.  Mutation  detection  is  consistent  with
haplotyping  of  those  two  members.  This  nucleotide
substitution was not observed in 50 control subjects from the
same ethnic background.
DISCUSSION
In the present study, we identified a novel mutation (R974C)
in  FBN1  from  a  Chinese  family  with  isolated  EL.  This
missense variation is found in all the affected family members.
The  mutation  leads  to  a  cysteine  substitution  for  highly
conserved arginine in the 8-Cys repeat latent transforming
growth factor-beta binding protein (LTBP) motif encoded by
FBN1 exon 25.
To date, over 600 mutations in FBN1 have been reported.
The relationship between the genotype and the phenotype is
still  not  clear  [12].  Some  information  is  concluded  from
TABLE 1. RESULT OF LINKAGE ANALYSIS.
    LOD scores at θ=
Marker Physical distance (M) 0.00 0.01 0.10 0.20 0.30 0.40
D15S992 48.8 2.23 2.19 1.82 1.38 0.89 0.37
MTS-1 48.9 0.12 0.12 0.10 0.08 0.05 0.03
FBN1 48.7–48.9          
D15S1082 49.0 2.06 2.02 1.67 1.26 0.80 0.33
D15S126 49.3 2.61 2.57 2.16 1.66 1.10 0.48
Figure 3. DNA sequence analysis of FBN1 in unaffected and affected individuals. A heterozygous change C>T at codon 974 (CGC-C/TGC),
resulting in the substitution of arginine to cysteine (p.R974C) in the affected individuals.
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947reported  materials  by  researchers  [13].  For  instance,
mutations in exons 24–32 of FBN1 are usually associated with
a severe form of Marfan syndrome (MFS), called neonatal
MFS  [13].  Mutations  of  cysteine  substitution  are  usually
associated with isolated EL [14]. On the another hand, some
facts obstruct the conclusion, including mutations in the exons
24–32 of FBN1 caused MFS and isolated EL, and the same
mutation can cause MFS and isolated EL in different families.
Since  these  conclusions  were  obtained  from  the  clinical
materials, but not from the pathogenic mechanism, we can not
correlate  the  genotype  and  the  phenotype  from  clinical
symptoms  only.  So,  we  need  to  explain  the  pathogenic
mechanism on the molecular biologic level.
Fibrillin-1 is a large (320 kDa) multidomain glycoprotein
that is a main component of the 10 to 12 nm sized extracellular
microfibrils found in a wide range of tissues. Fibrillin-1 is
considered to be important for elastogenesis, elasticity, and
homeostasis of elastic fibers [15,16].
In  the  previous  experiments,  researchers  found  that
fibrillin-1 was not only a structural component of extracellular
matrix but also was a mediator of the transforming growth
factor-beta (TGFβ) signaling pathway [17,18]. Mutations that
influence the TGFβ signaling pathway are believed to cause
severe multiple defects [19].
Through  a  literature  search,  eighteen  mutations  of
FBN1  causing  EL  were  found  [8-10,14,20-23].  In  these
mutations, three mutations of FBN1 can cause EL and MFS
in different families. Mutations of cysteine substitution were
found in fifteen families [8-10].
In this study, we found the extra created cysteine in the
LTBP motif only results in isolated EL. This suggests that the
correct cysteine localization and disulfide binding play an
important role in the structural integrity of the lens suspensory
ligaments.  The  change  has  no  or  slight  effect  in  the
extracellular matrix of other organs.
It is reported that some specified mutation can cause MFS
and isolated EL in different families. This may be influenced
by genetic or environmental modifiers.
In summary, we report a novel conserved arginine to
cysteine substitution in exon 25 of FBN1 which is associated
with isolated EL. Our results further expanded the mutation
spectrum of FBN1 and provided useful materials to the further
researches.
REFERENCES
1. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz
RE. Revised diagnostic criteria for the Marfan syndrome. Am
J Med Genet 1996; 62:417-26. [PMID: 8723076]
2. Kainulainen K, Pulkkinen L, Savolainen A, Kaitila I, Peltonen
L. Location on chromosome 15 of the gene defect causing
Marfan syndrome. N Engl J Med 1990; 323:935-9. [PMID:
2402262]
3. Dietz  HC,  Pyeritz  RE,  Hall  BD,  Cadle  RG,  Hamosh  A,
Schwartz  J,  Meyers  DA,  Francomano  CA.  The  Marfan
syndrome locus: confirmation of assignment to chromosome
15 and identification of tightly linked markers at 15q15-q21.3.
Genomics 1991; 9:355-61. [PMID: 2004786]
4. Magenis  RE,  Maslen  CL,  Smith  L,  Allen  L,  Sakai  LY.
Localization of the fibrillin (FBN) gene to chromosome 15,
band q21.1. Genomics 1991; 11:346-51. [PMID: 1769651]
5. Lee B, Godfrey M, Hori H, Mattei MG, Sarfarazi M, Tsipouras
P, Ramirez F, Hollister DW. Linkage of Marfan syndrome
and a phenotypically related disorder to two different fibrillin
genes. Nature 1991; 352:330-4. [PMID: 1852206]
6. Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY,
Corson GM, Puffenberger EG, Hamosh A, Nanthakumar EJ,
Curristin  SM,  Stetten  G,  Meyers  DA,  Francomano  CA.
Marfan syndrome caused by a recurrent de novo missense
mutation  in  the  fibrillin  gene.  Nature  1991;  352:337-9.
[PMID: 1852208]
7. Lönnqvist L, Child A, Kainulainen K, Davidson R, Puhakka L,
Peltonen L. A novel mutation of the fibrillin gene causing
ectopia lentis. Genomics 1994; 19:573-6. [PMID: 8188302]
8. Yu R, Lai Z, Zhou W, Ti DD, Zhang XN. Recurrent FBN1
mutation (R62C) in a Chinese family with isolated ectopia
Figure 4. The alignment of amino acids of FBN1 from Bos taurus, Rattus norvegicus, Mus musculus, and Homo sapiens. The Arg974 residue
is highly conserved during evolution.
Molecular Vision 2012; 18:945-950 <http://www.molvis.org/molvis/v18/a98> © 2012 Molecular Vision
948lentis.  Am  J  Ophthalmol  2006;  141:1136-8.  [PMID:
16765689]
9. Deng T, Dong B, Zhang X, Dai H, Li Y. Late-onset bilateral
lens  dislocation  and  glaucoma  associated  with  a  novel
mutation  in  FBN1.  Mol  Vis  2008;  14:1229-33.  [PMID:
18615205]
10. Vanita V, Singh JR, Singh D, Varon R, Robinson PN, Sperling
K. A recurrent FBN1 mutation in an autosomal dominant
ectopia  lentis  family  of  Indian  origin.  Mol  Vis  2007;
13:2035-40. [PMID: 18079676]
11. Nijbroek G, Sood S, McIntosh I, Francomano CA, Bull E,
Pereira L, Ramirez F, Pyeritz RE, Dietz HC. Fifteen novel
FBN1  mutations  causing  Marfan  syndrome  detected  by
heteroduplex  analysis  of  genomic  amplicons.  Am  J  Hum
Genet 1995; 57:8-21. [PMID: 7611299]
12. The  FBN1  Gene  Mutations  Database.  http://www.umd.be/
FBN1/http://www.umd.be/FBN1/
13. Faivre L, Collod-Beroud G, Loeys BL, Child A, Binquet C,
Gautier  E,  Callewaert  B,  Arbustini  E,  Mayer  K,  Arslan-
Kirchner M, Kiotsekoglou A, Comeglio P, Marziliano N,
Dietz HC, Halliday D, Beroud C, Bonithon-Kopp C, Claustres
M, Muti C, Plauchu H, Robinson PN, Adès LC, Biggin A,
Benetts B, Brett M, Holman KJ, De Backer J, Coucke P,
Francke U, De Paepe A, Jondeau G, Boileau C. Effect of
mutation  type  and  location  on  clinical  outcome  in  1,013
probands with Marfan syndrome or related phenotypes and
FBN1 mutations: an international study. Am J Hum Genet
2007; 81:454-66. [PMID: 17701892]
14. Adès LC, Holman KJ, Brett MS, Edwards MJ, Bennetts B.
Ectopia lentis phenotypes and the FBN1 gene. Am J Med
Genet 2004; 126A:284-9. [PMID: 15054843]
15. Sakai  LY,  Keene  DR,  Engvall  E.  Fibrillin,  a  new  350-kD
glycoprotein, is a component of extracellular microfibrils. J
Cell Biol 1986; 103:2499-509. [PMID: 3536967]
16. Sakai  LY,  Keene  DR,  Glanville  RW,  Bächinger  HP.
Purification  and  partial  characterization  of  fibrillin,  a
cysteine-rich  structural  component  of  connective  tissue
microfibrils.  J  Biol  Chem  1991;  266:14763-70.  [PMID:
1860873]
17. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton
TE,  Gayraud  B,  Ramirez  F,  Sakai  LY,  Dietz  HC.
Dysregulation  of  TGF-b  activation  contributes  to
pathogenesis  in  Marfan  syndrome.  Nat  Genet  2003;
33:407-11. [PMID: 12598898]
18. Chaudhry SS, Cain SA, Morgan A, Dallas SL, Shuttleworth CA,
Kielty CM. Fibrillin-1 regulates the bioavailability of TGFb1.
J Cell Biol 2007; 176:355-67. [PMID: 17242066]
19. Mizuguchi  T,  Collod-Beroud  G,  Akiyama  T,  Abifadel  M,
Harada N, Morisaki T, Allard D, Varret M, Claustres M,
Morisaki H, Ihara M, Kinoshita A, Yoshiura K, Junien C,
Kajii  T,  Jondeau  G,  Ohta  T,  Kishino  T,  Furukawa  Y,
Nakamura  Y,  Niikawa  N,  Boileau  C,  Matsumoto  N.
Heterozygous TGFBR2 mutations in Marfan syndrome. Nat
Genet 2004; 36:855-60. [PMID: 15235604]
20. Jin C, Yao K, Jiang J, Tang X, Shentu X, Wu R. Novel FBN1
mutations  associated  with  predominant  ectopia  lentis  and
marfanoid  habitus  in  Chinese  patients.  Mol  Vis  2007;
13:1280-4. [PMID: 17679947]
21. Sui RF, Wei HB, Zhao JL, Hu SY, Wang B, Huang SZ, Dong
M. Novel mutation of fibrillin 1 gene cause ectopia lentis in
a  Chinese  family.  Zhonghua  Yan  Ke  Za  Zhi  2004;
40:828-31. [PMID: 15733436]
22. Comeglio P, Johnson P, Arno G, Brice G, Evans A, Aragon-
Martin  J,  da  Silva  FP,  Kiotsekoglou  A,  Child  A.  The
importance of mutation detection in Marfan syndrome and
Marfan-related  disorders:  report  of  193  FBN1  mutations.
Hum Mutat 2007; 28:928. [PMID: 17657824]
23. Loeys  B,  Nuytinck  L,  Delvaux  I,  De  Bie  S,  De  Paepe  A.
Genotype and phenotype analysis of 171 patients referred for
molecular  study  of  the  fibrillin-1  gene  FBN1  because  of
suspected  Marfan  syndrome.  Arch  Intern  Med  2001;
161:2447-54. [PMID: 11700157]
Molecular Vision 2012; 18:945-950 <http://www.molvis.org/molvis/v18/a98> © 2012 Molecular Vision
949Appendix 1. Table 1. FBNI primers and conditions for PCR.
To access the data, click or select the words “Appendix
1.” This will initiate the download of a compressed (pdf)
archive that contains the file.
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